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Sir,
Your recent article by Garcı ´a-Closas et al (2006) raises
interesting discussion points regarding tumour behaviour in
Poland. If correct, these results may have implications for health
care in Poland, but we disagree that the findings can be generalised
to other populations, particularly when the reported ER negativity
was 41%. There were several flaws in the study design and analysis
that make such a conclusion unsafe. Firstly, we understand
mammographic screening is not routine in Poland (reflected in the
low incidence (6%) of DCIS). The authors should have made clear
whether mammography was in fact offered to equal numbers in the
study and control groups. It is possible that the results were biased
by differential access to and uptake of mammography between the
groups; perhaps, better educated women were both more likely to
take HRT and seek mammograms. Indeed, the absolute differences
for better education between the two arms (10%, unadjusted
OR¼1.89) and history of a previous mammogram (8%, un-
adjusted OR¼1.39) support this suggestion.
Another potential error lies in the histology. The rate of agreement
between the original Polish and the subsequent American analysis
varied from 18 to 80%, depending on tissue type. However, nearly one
in five (n¼428) did not benefit from an American review, yet were
still included in the study. With such high rates of discordance, it was
hazardous to assume the original diagnosis was correct in the
nonreviewed group. If the ratios for error are the same as the reviewed
group, then at least 4.9% of all samples would have been misclassified,
thus challenging many of the statistical results (see Table 1).
Analysis of data from studies of this kind is fraught with
difficulties and such statistical methods are not always illuminat-
ing. We believe there is a great potential for over interpretation.
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Table 1 Analysis of potential misclassification in nonreviewed histology
% of reviewed
histology
Reported
discordance (%)
Projected number of
nonreviewed cases
Projected
misclassification in
nonreviewed cases
Proportion to total
sample (%)
Ductal 58 20 428*58% 248*20% 2.2
248 cases 50 cases
Lobular 16 32 428*16% 68*32% 0.9
69 cases 22 cases
Mixed 12 82 428*12% 51*82% 1.8
51 cases 42 cases
Other 14 No data:
Assume¼0
428*14% —
60 cases 0 cases
Total 100 — 428 cases 114 cases 4.9
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